國立虎尾科技大學 |

Radiopharmaceuticals for Therapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Radiopharmaceuticals for Therapy / by F. F. (Russ) Knapp, Ashutosh Dash.
Author:	Knapp, F. F. (Russ).
other author:	Dash, Ashutosh.
Description:	XXIV, 347 p. 157 illus., 85 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Nuclear medicine. -
Online resource:	https://doi.org/10.1007/978-81-322-2607-9
ISBN:	9788132226079

Radiopharmaceuticals for Therapy
Knapp, F. F. (Russ).

Radiopharmaceuticals for Therapy [electronic resource] /by F. F. (Russ) Knapp, Ashutosh Dash. - 1st ed. 2016. - XXIV, 347 p. 157 illus., 85 illus. in color.online resource.

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.

ISBN: 9788132226079

Standard No.: 10.1007/978-81-322-2607-9doiSubjects--Topical Terms:

673902
Nuclear medicine.

LC Class. No.: R895-920

Dewey Class. No.: 616.07548

Radiopharmaceuticals for Therapy
LDR:02778nam a22003855i 4500 001 979429
003 DE-He213
005 20200629144507.0
007 cr nn 008mamaa
008 201211s2016 ii | s |||| 0|eng d
020 $a 9788132226079 $9 978-81-322-2607-9
024 7 $a 10.1007/978-81-322-2607-9 $2 doi
035 $a 978-81-322-2607-9
050 4 $a R895-920
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.07548 $2 23
100 1 $a Knapp, F. F. (Russ). $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1272515
245 1 0 $a Radiopharmaceuticals for Therapy $h [electronic resource] / $c by F. F. (Russ) Knapp, Ashutosh Dash.
250 $a 1st ed. 2016.
264 1 $a New Delhi : $b Springer India : $b Imprint: Springer, $c 2016.
300 $a XXIV, 347 p. 157 illus., 85 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
520 $a This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650 0 $a Nuclear medicine. $3 673902
650 0 $a Pharmacotherapy. $3 973587
650 0 $a Oncology . $3 1253469
650 0 $a Endocrinology . $3 1254221
650 1 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Oncology. $3 593951
650 2 4 $a Endocrinology. $3 645497
700 1 $a Dash, Ashutosh. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1105544
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9788132226062
776 0 8 $i Printed edition: $z 9788132226086
776 0 8 $i Printed edition: $z 9788132237983
856 4 0 $u https://doi.org/10.1007/978-81-322-2607-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)